Nicotinamide Phosphoribosyltransferase (NAMPT) as a Therapeutic Target in BRAF-Mutated Metastatic Melanoma.
J Natl Cancer Inst
; 110(3)2018 03 01.
Article
in En
| MEDLINE
| ID: mdl-29309612
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Biomarkers, Tumor
/
Drug Resistance, Neoplasm
/
Proto-Oncogene Proteins B-raf
/
Nicotinamide Phosphoribosyltransferase
/
Melanoma
/
Mutation
Type of study:
Prognostic_studies
Limits:
Animals
/
Humans
/
Male
Language:
En
Journal:
J Natl Cancer Inst
Year:
2018
Document type:
Article
Affiliation country:
Italia
Country of publication:
Estados Unidos